Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced that Managed Waste Service plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales ...
SMARTOX deployed over 50 INBS fingerprint drug screening readers, conducting 7,000 tests, as FDA clearance for U.S. expansion is pursued. Intelligent Bio Solutions Inc. (INBS) has announced ...
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening ...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced an update on its growing footprint in the U.S. Forensic Use Only Market on Wednesday through its strategic partnership with SMARTOX. SMARTOX, ...
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
The new customer account represents one of INBS's most significant UK commercial deployments to date, the company said. Intelligent Bio’s Intelligent Fingerprinting Drug Screening System uses ...
Intelligent Bio Solutions ( (INBS)) has issued an announcement. On September 1, 2026, Intelligent Bio Solutions Inc. reported results from a multi-site Method Comparison Study of its Intelligent ...
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results